Our findings are consistent with those from four previous studies of XRCC1 polymorphisms and breast cancer risk that reported an inverse association between the Trp194 carriers and breast cancer risk in mostly Caucasian [7,14] and other [15,22] ethnic populations. Here, XRCC1 is linked to breast carcinoma.